Systemic therapy in advanced hepatocellular carcinoma
Joseph C. Ahn, Nguyen H. Tran, Ju Dong Yang
Clin Mol Hepatol. 2023;29(2):516-519.   Published online 2023 Feb 20     DOI: https://doi.org/10.3350/cmh.2023.0051
Citations to this article as recorded by Crossref logo
Disparities in Immunotherapy Use Prior to First-Line Approval for Metastatic Hepatocellular Carcinoma in the United States
Manav Shah, Abdullah Khalid, Oliver Standring, Neda Amini, Lyudmyla Demyan, Shruti Koti, Emma Gazzara, Grace Wu, Nandan Vithlani, Danielle DePeralta, Sepideh Gholami, Matthew Weiss
Onco.2025; 5(1): 6.     CrossRef
Current Landscape of Adoptive Cell Therapy and Challenge to Develop “Off‐The‐Shelf” Therapy for Hepatocellular Carcinoma
Seung Kak Shin, Yuta Mishima, Yoonseok Lee, Oh Sang Kwon, Ju Hyun Kim, Yun Soo Kim, Shin Kaneko
Journal of Gastroenterology and Hepatology.2025; 40(4): 791.     CrossRef
T cell-related ubiquitination genes as prognostic indicators in hepatocellular carcinoma
Chaobo Chen, Zheng Chen, Zheyu Zhou, Hui Ye, Shaohui Xiong, Weidong Hu, Zipeng Xu, Chen Ge, Chunlong Zhao, Decai Yu, Jiapei Shen
Frontiers in Immunology.2024;[Epub]     CrossRef
CCL5/CCR5/CYP1A1 pathway prompts liver cancer cells to survive in the combination of targeted and immunological therapies
Yafei Wang, Biao Gao, Tianyu Jiao, Wenwen Zhang, Huizhong Shi, Hao Jiang, Xuerui Li, Junfeng Li, Xinlan Ge, Ke Pan, Chonghui Li, Guankun Mao, Shichun Lu
Cancer Science.2024; 115(11): 3552.     CrossRef
An Early Increase in IL-10 and TNF-α Levels Following Atezolizumab Plus Bevacizumab Treatment Predicts Survival in Advanced Hepatocellular Carcinoma Patients: A Prospective Cohort Study
Soon Kyu Lee, Soon Woo Nam, Ji Won Han, Jung Hyun Kwon
Cancers.2024; 16(20): 3543.     CrossRef
Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Clinical and Molecular Hepatology.2023; 29(2): 252.     CrossRef
The prime time for management of hepatocellular carcinoma in Hong Kong
Landon L. Chan, Stephen L. Chan
Clinical and Molecular Hepatology.2023; 29(2): 345.     CrossRef
What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?
Min Kyung Park, Yoon Jun Kim
Clinical and Molecular Hepatology.2023; 29(2): 332.     CrossRef